Edgewise Therapeutics Announces Positive Topline Results From th

EWTX: Edgewise Therapeutics, Inc.
2022-01-05 08:00:00
Edgewise Therapeutics Announces Positive Topline Results From the EDG-5506 Phase 1b Clinical Trial in Adults With Becker Muscular Dystrophy (BMD)
Beyond Technical Analysis

إخلاء المسؤولية